Blujepa, the first new oral UTI antibiotic in 30 years, offers hope against antibiotic-resistant infections, improving ...

If you deal with recurrent UTIs, a new FDA-approved antibiotic called Blujepa could offer another treatment option—especially ...

GSK's Blujepa (gepotidacin) becomes the first in a new class of oral antibiotics to treat uncomplicated UTIs (also known as uUTIs) in almost 30 years, taking aim at infection-causing bacteria ...

A devastating 77-magnitude earthquake struck Myanmar unleashing energy equal to 334 atomic bombs Experts warn of lasting ...

GSK’s share price has fallen a long way from its one-year high, which has only increased the major undervaluation I'd seen in the stock before that. The post GSK’s share price looks a steal to me ...

Positive as well were new approvals for several GSK drugs. In March alone, the US Food and Drug Administration approved Blujepa for the treatment of uncomplicated urinary tract infections.